Open AccessBudget impact analysis of rituximab biosimilar in Italy from the hospital and payer perspectives
Author(s) -
Carla Rogi,
Arianna Bertolani,
Claudio Jommi
Publication year - 2018
Publication title -
global and regional health technology assessment
Language(s) - English
Resource type - Journals
eISSN - 2283-5733
pISSN - 2284-2403
DOI - 10.1177/2284240318784289
Subject(s) - biosimilar , pharmacoeconomics , rituximab , medicine , reimbursement , actuarial science , intensive care medicine , health care , business , lymphoma , economics , economic growth
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom